Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker HTFL
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Farquhar John C.M. Chief Executive Officer, Director | HTFL Heartflow, Inc. | Sale | 38,900 | $55.74 | $2.2M Sale | Form 4 ↗ |
| Nov 9, 2026 | Vikram Verghese Chief Financial Officer | HTFL Heartflow, Inc. | Sale | 3,587 | $53.15 | $190.6K Sale | Form 4 ↗ |
| Oct 22, 2026 | Campbell Rogers Chief Medical Officer | HTFL Heartflow, Inc. | Sale | 23,933 | $55.01 | $1.3M Sale | Form 4 ↗ |
| Sep 18, 2026 | Campbell Rogers Chief Medical Officer | HTFL Heartflow, Inc. | Sale | 19,682 | $50.15 | $987.1K Sale | Form 4 ↗ |
| Sep 18, 2026 | Vikram Verghese Chief Financial Officer | HTFL Heartflow, Inc. | Sale | 16,766 | $50.75 | $850.9K Sale | Form 4 ↗ |
| Sep 17, 2026 | Vikram Verghese Chief Financial Officer | HTFL Heartflow, Inc. | Sale | 7,579 | $50.11 | $379.8K Sale | Form 4 ↗ |
| Sep 15, 2026 | Vikram Verghese Chief Financial Officer | HTFL Heartflow, Inc. | Sale | 668 | $50.01 | $33.4K Sale | Form 4 ↗ |
| Sep 14, 2026 | Vikram Verghese Chief Financial Officer | HTFL Heartflow, Inc. | Sale | 4,593 | $50.24 | $230.8K Sale | Form 4 ↗ |
| Sep 11, 2026 | Vikram Verghese Chief Financial Officer | HTFL Heartflow, Inc. | Sale | 29,714 | $50.06 | $1.5M Sale | Form 4 ↗ |
| Sep 11, 2026 | Farquhar John C.M. Chief Executive Officer, Director | HTFL Heartflow, Inc. | Sale | 3,890 | $50.00 | $194.5K Sale | Form 4 ↗ |
| Sep 10, 2026 | Farquhar John C.M. Chief Executive Officer, Director | HTFL Heartflow, Inc. | Sale | 35,010 | $46.42 | $1.6M Sale | Form 4 ↗ |
| Sep 8, 2026 | Vikram Verghese Chief Financial Officer | HTFL Heartflow, Inc. | Sale | 6,640 | $50.03 | $332.2K Sale | Form 4 ↗ |
| Sep 3, 2026 | Vikram Verghese Chief Financial Officer | HTFL Heartflow, Inc. | Sale | 27,540 | $49.69 | $1.4M Sale | Form 4 ↗ |
| Sep 2, 2026 | Vikram Verghese Chief Financial Officer | HTFL Heartflow, Inc. | Sale | 5,876 | $50.60 | $297.3K Sale | Form 4 ↗ |
| Aug 21, 2026 | Farquhar John C.M. Chief Executive Officer, Director | HTFL Heartflow, Inc. | Sale | 27,230 | $50.00 | $1.4M Sale | Form 4 ↗ |
| Aug 18, 2026 | Farquhar John C.M. Chief Executive Officer, Director | HTFL Heartflow, Inc. | Sale | 32,676 | $45.00 | $1.5M Sale | Form 4 ↗ |
| Aug 17, 2026 | Campbell Rogers Chief Medical Officer | HTFL Heartflow, Inc. | Sale | 9,219 | $41.23 | $380.1K Sale | Form 4 ↗ |
| Aug 14, 2026 | Farquhar John C.M. Chief Executive Officer, Director | HTFL Heartflow, Inc. | Sale | 15,560 | $39.06 | $607.8K Sale | Form 4 ↗ |
| Aug 10, 2026 | Farquhar John C.M. Chief Executive Officer, Director | HTFL Heartflow, Inc. | Sale | 22,562 | $28.31 | $638.7K Sale | Form 4 ↗ |
| Jul 15, 2026 | Campbell Rogers Chief Medical Officer | HTFL Heartflow, Inc. | Sale | 9,219 | $25.72 | $237.1K Sale | Form 4 ↗ |
| Jul 10, 2026 | Farquhar John C.M. Chief Executive Officer, Director | HTFL Heartflow, Inc. | Sale | 22,562 | $27.75 | $626.1K Sale | Form 4 ↗ |
| Jun 24, 2026 | Farquhar John C.M. Chief Executive Officer, Director | HTFL Heartflow, Inc. | Sale | 38,900 | $35.00 | $1.4M Sale | Form 4 ↗ |
| Jun 10, 2026 | Farquhar John C.M. Chief Executive Officer, Director | HTFL Heartflow, Inc. | Sale | 22,562 | $28.50 | $643.0K Sale | Form 4 ↗ |
| May 18, 2026 | Campbell Rogers Chief Medical Officer | HTFL Heartflow, Inc. | Sale | 9,219 | $28.34 | $261.3K Sale | Form 4 ↗ |
| May 11, 2026 | Farquhar John C.M. Chief Executive Officer, Director | HTFL Heartflow, Inc. | Sale | 22,562 | $29.12 | $657.0K Sale | Form 4 ↗ |
| Apr 30, 2026 | Bain Capital Life Sciences III General Partner, LLC 10% owner | HTFL Heartflow, Inc. | Sale | 56,224 | $30.05 | $1.7M Sale | Form 4 ↗ |
| Apr 30, 2026 | Bain Capital Life Sciences III General Partner, LLC 10% owner | HTFL Heartflow, Inc. | Sale | 892,533 | $29.18 | $26.0M Sale | Form 4 ↗ |
| Apr 29, 2026 | Bain Capital Life Sciences III General Partner, LLC 10% owner | HTFL Heartflow, Inc. | Sale | 797,133 | $29.37 | $23.4M Sale | Form 4 ↗ |
| Apr 28, 2026 | Bain Capital Life Sciences III General Partner, LLC 10% owner | HTFL Heartflow, Inc. | Sale | 254,110 | $30.51 | $7.8M Sale | Form 4 ↗ |
| Apr 10, 2026 | Farquhar John C.M. Chief Executive Officer, Director | HTFL Heartflow, Inc. | Sale | 22,562 | $26.72 | $602.9K Sale | Form 4 ↗ |
| Apr 1, 2026 | Campbell Rogers Chief Medical Officer | HTFL Heartflow, Inc. | Sale | 64,533 | $24.64 | $1.6M Sale | Form 4 ↗ |
| Mar 19, 2026 | Campbell Rogers Chief Medical Officer | HTFL Heartflow, Inc. | Sale | 64,533 | $25.69 | $1.7M Sale | Form 4 ↗ |
| Mar 18, 2026 | Farquhar John C.M. Chief Executive Officer, Director | HTFL Heartflow, Inc. | Sale | 9,725 | $25.00 | $243.1K Sale | Form 4 ↗ |
| Mar 10, 2026 | Farquhar John C.M. Chief Executive Officer, Director | HTFL Heartflow, Inc. | Sale | 12,837 | $22.66 | $290.9K Sale | Form 4 ↗ |
| Mar 5, 2026 | Julie A. Cullivan Director | HTFL Heartflow, Inc. | Sale | 9,122 | $25.00 | $228.1K Sale | Form 4 ↗ |
| Feb 12, 2026 | Campbell Rogers Chief Medical Officer | HTFL Heartflow, Inc. | Sale | 65,153 | $24.49 | $1.6M Sale | Form 4 ↗ |
| Feb 10, 2026 | Farquhar John C.M. Chief Executive Officer, Director | HTFL Heartflow, Inc. | Sale | 22,562 | $27.46 | $619.6K Sale | Form 4 ↗ |
| Feb 5, 2026 | Julie A. Cullivan Director | HTFL Heartflow, Inc. | Sale | 8,000 | $27.32 | $218.6K Sale | Form 4 ↗ |
| Feb 4, 2026 | Bain Capital Life Sciences Investors, LLC 10% owner | HTFL Heartflow, Inc. | Sale | 2.00M | $28.05 | $56.1M Sale | Form 4 ↗ |
| Dec 16, 2025 | Jeffrey C. Lightcap Director | HTFL Heartflow, Inc. | Buy | 40,000 | $26.34 | $1.1M Buy | Form 4 ↗ |
40 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:54 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances